Skip to content

The Muscle Quality Index: linking quantitative MRI to muscle function

The Muscle Quality Index: linking quantitative MRI to muscle function - Motion

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON56280
Enrollment
162
Registered
2023-01-18
Start date
2023-02-28
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

concerns study in healthy volunteers N/A

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
16 Years to 64 Years

Inclusion criteria

Inclusion criteria: • Age between 16 and 60 years old • BMI between 18 and 30 kg/m2

Exclusion criteria

Exclusion criteria: • History of neuromuscular disease • Contra-indications for undergoing an MRI scan (e.g. because of pacemaker, claustrophobia, metal implants, metal splinters in the eye) • Inability to lie supine for 60 minutes • Inability to perform knee extension or knee flexion • Contra-indications for physical exercise without prior consultation with a physician verified using the Physical Activity Readiness Questionnaire (PAR-Q).

Design outcomes

Primary

MeasureTime frame
The primary outcome measures are isometric and isokinetic muscle force and the obtained qMRI parameters: - Muscle fat fraction, muscle volume, muscle length, and muscle shape assessed with a Dixon sequence. - T2 relaxation time of muscle water (T2water) assessed with a multi-slice multi spin echo sequence. - Mean diffusivity, fractional anisotropy, estimated muscle fibre length, muscle pennation angle and physiological cross-sectional area assessed with a diffusion weighted sequence. Other study parameters are the potential confounders in qMRI, like age, body weight, height, and composition, daily-life activity levels, and smoking and drinking history.

Secondary

MeasureTime frame
n.a.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)